JM Zaucha, S Chauvie, R Zaucha, A Biggii… - Cancer treatment …, 2019 - Elsevier
Abstract Classical Hodgkin Lymphoma is distinguished from other lymphomas by its peculiar biology and heterogeneous chemosensitivity. Most of the patients respond to the standard …
MG Mei, HJ Lee, JM Palmer, R Chen… - Blood, The Journal …, 2022 - ashpublications.org
This phase 2 trial evaluated PET-adapted nivolumab alone or in combination with ifosfamide, carboplatin, and etoposide (NICE) as first salvage therapy and bridge to …
P Blanc-Durand, S Jégou, S Kanoun… - European Journal of …, 2021 - Springer
Purpose Lymphoma lesion detection and segmentation on whole-body FDG-PET/CT are a challenging task because of the diversity of involved nodes, organs or physiological …
Purpose To determine whether [18 F] FDG PET/CT-derived radiomic features alone or in combination with clinical, laboratory and biological parameters are predictive of 2-year …
L van Heek, C Stuka, H Kaul, H Müller, J Mettler, F Hitz… - BMC cancer, 2022 - Springer
Abstract Background 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) plays an important role in the staging and response assessment of lymphoma patients. Our …
J Driessen, GJC Zwezerijnen, H Schöder… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Consensus about a standard segmentation method to derive metabolic tumor volume (MTV) in classical Hodgkin lymphoma (cHL) is lacking, and it is unknown how different …
CA Voltin, J Mettler, J Grosse, M Dietlein, C Baues… - Cancers, 2020 - mdpi.com
Since the mid-1990s, 18F-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination with computed tomography has come to play a prominent role in the …